Acetylation phenotype and clinical implications in tuberculosis patients

- Profile of Isoniazid Acetylation Phenotype and Clinical Implications in Rwandan Healthy Subjects and Tuberculosis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201310000604277

Enrollment

Registered

2013-07-29

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

Healthy volunteers

Clinical outcomes

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy student volunteer Tuberculosis patient Consult the University hospital both sexes

Exclusion criteria

Exclusion criteria: pregnancy under other treatment less than 15 years treated with ARVs

Design outcomes

Primary

Measure	Time frame
Acetylator class: slow, intermediate, fast	—

Secondary

Measure	Time frame
Impact of Phenotype on clinical outcomes	—

Countries

Rwanda

Contacts

Public ContactAndre Musemakweri

Physician/NUR CHUB

amusemakweri@nur.ac.rw+250788592150

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026